The Swedish Experience Otto Cars Prof. Infectious Diseases Uppsala University Hospital Sweden.

Slides:



Advertisements
Similar presentations
New Challenges in M&E Lets go. Scaling Up Monitoring & Evaluation Strategic Information PROGRAM GUIDANCE RESULT NEEDS OPPORTUNITIES Resources New directions.
Advertisements

SWEDRES 2001 Figures and Tables. 3. Use of antimicrobials.
Informatics priorities and strategy Chris Carrigan Deputy to the PHE Chief Knowledge Officer, Information Services.
The National Audit of Falls and Bone Health in Older People [Speaker’s name and designation] On behalf of the Clinical Effectiveness and Evaluation Unit,
Skoog G, Cars O, Skärlund K, Elowson S, Hanberger H, Odenholt I, Prag M, Struwe J, Torell E, Ulleryd P, Erntell M STRAMA, Swedish Institute for Infectious.
G aps, challenges and opportunities Theo Verheij University Medical Center Utrecht Lower Respiratory Tract Infections in Primary Care.
EDUCATIONAL INTERVENTION TO IMPROVE PRESCRIBING HABITS OF PEDIATRICIANS IN TREATMENT OF UNCOMPLICATED ACUTE UPPER RESPIRATORY TRACT INFECTION Ziganshina.
STRAMA A 10 year perspective Swedish Strategic programme for the Rational use of Antimicrobial Agents and Surveillance of Resistance
Antimicrobial resistance “One health fits all”
1 Institute of Epidemiology and Infectious Diseases Research Activities The L.V. Gromashevsky Institute of Epidemiology and Infectious Diseases Svetlana.
TBS November 4, |1 | AMR and appropriate use of antimicrobials Nicola Magrini and Jane Robertson Policy, Access and Use Team, EMP TBS 4 November.
Concept To develop a low cost, consistent end of life care programme, available to all care homes. It will support the development of nominated staff.
Hans Wolf-Watz, professor, UCMR, MIMS, Department of Microbiology, Umeå University, Sweden, Antibiotic resistance a new.
Libyan-UK partnership on Infectious Diseases Control Professor Abdulhafid A. Abudher MBBch,DGO,FRCOG,MD,FABOG Director of National Centre for Infectious.
WHO local pilot projects to contain AMR ICIUM 2004 K.A.Holloway and T.L.Sorensen Essential Drugs and Medicines Policy WHO Geneva.
Key Strategies for Improving Use of Existing and New Antibiotics -the European Experience Otto Cars Professor Inf. Diseases, Uppsala University, Sweden.
The WHO Global Alcohol Strategy: What Role for Industry? Jim Finkle FIVS President Istanbul, Turkey 14 June 2012.
Improving Antibiotic use through a Nationwide Decentralized Project – A Nine-Year Experience Cars O, Stålsby Lundborg C, Mölstad S Swedish Strategic Programme.
A National Approach to Cancer Control in Canada Remarks by Jeff Lozon, Chair Canadian Partnership Against Cancer.
Roles of the DSCT team members Review of documents available.
Recommendation on prudent use of antimicrobial agents in human medicine – Slovenian experiences Intersectoral Coordination Mechanism Prof. Milan Čižman,
Infection Control Clinical Pharmacy and Patient Safety
National antibiotic program in the Czech Republic NAP-CZ Vlastimil Jindrák and Subcommitte for antibiotic policy ČLS JEP.
Organization and guideline development April 2010 ACCC The Netherlands.
Antimicrobial Resistance patterns among nosocomial gram negative bacilli by E-test and disc diffusion methods in Sina and Imam Hospital.
Swedres 2005 Swedres 2005 Figures and tables. Swedres 2005 Table Total use of antibacterial drugs for systemic use in Sveden , DDD/1000/day.
Linda Devereux Associate Director Merseyside and Cheshire Cancer Network - why we are here and what’s next!
Using drug use evaluation (DUE) to optimise analgesic prescribing in emergency departments (EDs) Karen Kaye, Susie Welch. NSW Therapeutic Advisory Group*
PneumoNP presentation Nanotherapeutics to treat antibiotic resistant Gram- negative respiratory infections.
English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR) Figures Slideset.
TB infection control and prevention of XDR Group II.
European Centre for Disease Prevention and Control
Perspectives on containing antimicrobial resistance – ways to go … Karl Ekdahl, Strategic Advisor on behalf of Zsuzsanna Jakab, Director European Centre.
Evaluation of Structural Fund Programmes – the Swedish experience Implementation of the mid term evaluation - lessons for the future Maria Eriksson NUTEK.
Skoog G, Cars O, Skärlund K, Elowson S, Hanberger H, Odenholt I, Prag M, Struwe J, Torell E, Ulleryd P, Erntell M. STRAMA, Swedish Institute for Infectious.
RECENT ADVANCES IN PROVISION OF PRIMARY HEALTH CARE BY MISSION ORGANIZATIONS THE EFFECT OF AN EDUCATIONAL INTERVENTION ON USE OF ANTIBIOTICS IN THE TREATMENT.
Országos Epidemiológiai Központ National Center for Epidemiology, Budapest, Hungary Activities in Hungary for preventing AMR and controlling HCAI Emese.
An Audit to Determine if Prescribers are Reviewing Antimicrobial Prescriptions Hours After Initiation. Natalie Holman, Emma Cramp, Joy Baruah Hinchingbrooke.
Northern Dimension Antibiotic Resistance Study NoDARS Prof Jaana Vuopio, M.D., Ph.D., PAC 11 side-event, 19 November 2015, Berlin, Germany.
Prescribing of antibiotics in Slovenia in the period 1999 – 2015 Jurij Fürst ZZZS Slovenia 21 th EUMASS Congress and 4 th Congress of Medical Assessors.
Title of the Change Project
„ Can we change doctor’s prescribing antibiotic habits? “
Antibiotics: handle with care!
Antibiotics: handle with care!
WHO’s policy priorities and projects
Tackling antimicrobial resistance – what is the current situation in Europe? Dr Andrea Ammon, ECDC Director, 27 June 2017, European Parliament.
Antibiotics: handle with care!
TB- HIV Collaborative activities in Romania- may 2006 status
Introduction to Antimicrobial Resistance
Dr.Mowna Karthick M.D MICROBIOLOGY
How does teamwork improve value. Dr Nils E
Average susceptibility
Networks of hospitals: building a common strategy for HAI prevention and control and antimicrobial policy Tomasz Ozorowski, M.D. University of Medical.
Danijela Daus-Šebeđak
E. Monee’ Carter-Griffin DNP, RN, ACNP-BC
THE IMPORTANCE OF FEEDBACK TO ENHANCE THE IMPACT OF EFFECTIVE INTERVENTIONS TO REDUCE ANTIBIOTIC IN ACUTE RESPIRATORY-TRACT INFECTION authors: Yudatiningsih.
LONG-TERM IMPACT OF AN MTP APPROACH
Antibiotics, prescribed for outpatients in Sweden (ATC group J01 Excluding methenamine), DDD/1000/day,
Improving Antibiotic use through a Nationwide Decentralized Project –
This hospital is participating in the worldwide
Swedres 2007 Figures and tables Swedres 2007.
This hospital is participating in the worldwide
This hospital is participating in the worldwide
Blood borne viral hepatitis action in Wales
Our hospital is participating in the worldwide
B. Huttner, S. Harbarth, D. Nathwani 
This hospital is participating in the worldwide
Role of communicable disease control measures in affecting the spread of resistant pneumococci: the Swedish model  Karl Ekdahl, Otto Cars  Clinical Microbiology.
EARS-Net results 2011 Ole Heuer
EDUCATIONAL INTERVENTION TO IMPROVE PRESCRIBING HABITS OF PEDIATRICIANS IN TREATMENT OF UNCOMPLICATED ACUTE UPPER RESPIRATORY TRACT INFECTION Ziganshina.
Presentation transcript:

The Swedish Experience Otto Cars Prof. Infectious Diseases Uppsala University Hospital Sweden

The Global Challenge Antibiotics are losing their effect at a pace that was unforeseen just five years ago The pipeline of new drugs is empty The Global Challenge Antibiotics are losing their effect at a pace that was unforeseen just five years ago The pipeline of new drugs is empty

ESBL (CTX-M) producing Enterobacteriaceae

The consequences……. Bloodstream infection: 43.5% of the children with Gram- negative bloodstream infection died in a Tanzanian study (Blomberg, 2007). ESBL & MDR Gram-negatives: In Israel 3% of all fatalities in hospitals related to Gram-negative multiresistant nosocomial infections (Carmeli, 2006).

Clonal outbreak of av multiresistant Klebsiella pneumoniae Uppsala University Hospital

The Current Paradox: Antibiotic Resistance Drug Development MorbidityMortalityCosts

Hip replacement Transplants Cancer chemotherapy Infections in preterm babies

Overall objective To preserve effective antibacterial therapy for the future The Swedish Experience The Swedish Strategic Programme Against Antibiotic Resistance

NATIONAL LEVEL National co-ordinating group Surveillance National projects LOCAL LEVEL Local co-ordinating groups Implementation Behavioural change

Intensive care Hospital care Nursing homes Primary care Day care centres School children Projects and interventions initiated in many areas

NATIONAL LEVEL National co-ordinating group Surveillance National projects LOCAL LEVEL Local co-ordinating groups Implementation Behavioural change

Strama-groups were formed in every county. The County Medical Officers for Communicable have a leading role in these groups which include specialists from different medical fields The main objective is to evaluate the use antibiotics and antibacterial resistance in the region and to improve prescribing patterns

Strama-some examples of activities Local implementation of guidelines Sales statistics, Resistance data Feedback and audit Newsletter, website, Fund for local projects Educational activities “ Strama workshops”

Effect of prescriber feedback on consumption of fluoroquinolones in four primary care districts of Uppsala County DDD/1000ính/day

Effect of prescriber feedback on consumption of fluoroquinolones in four primary care districts of Uppsala County DDD/1000ính/day

Patient Prescriber Authorities MEDIA Awareness raising of all stakeholders through news media

”Små cipro” avser ciprofloxacin 100 mg 6 resp 10 tabl, 250 mg 10 tabl och 500 mg 10 tabl. Prescriptions of antibiotics for UTI (outpatients) Fluoroquinolones

Total sales of Antibiotics in the Nordic Countries * DDD/1000 inhabitants/day *Excluding Metenamine. Before 1998 figures from Denmark do not include hospital use.

Possible success factors Multidisciplinary coordinating group- involving all stakeholders Governmental support and mandate Decentralised organisation and local ownership Credible, scientifically based messages and actions Clear communication and media strategy

Conclusions It is possible to achieve a significant change in antibiotic use at the national level. To be sustainable, political/financial support is needed. Despite low antibiotic consumption resistance rates are incrasing

ReAct Action on Antibiotic Resistance